BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17891500)

  • 21. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans.
    Jin XM; Kim HN; Shin MH; Lee IK; Lee JS; Lee JH; Kim HJ; Choi JS; Juhng SW; Choi C
    DNA Cell Biol; 2011 Dec; 30(12):1039-44. PubMed ID: 21631283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
    Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
    Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses.
    Lissowska J; Gaudet MM; Brinton LA; Chanock SJ; Peplonska B; Welch R; Zatonski W; Szeszenia-Dabrowska N; Park S; Sherman M; Garcia-Closas M
    Int J Cancer; 2007 Jun; 120(12):2696-703. PubMed ID: 17311260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
    Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
    Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
    Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
    Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
    Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
    Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Shen M; Zhang Y; Wang SS; Zahm SH; Holford TR; Leaderer B; Boyle P; Chanock S
    Hum Genet; 2007 Apr; 121(2):161-8. PubMed ID: 17149600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
    Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
    PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
    Li G; Li D
    Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients.
    Wang YW; Zhang SD; Xue WJ; Zhu ML; Zheng LZ
    Chin J Cancer; 2015 Dec; 34(12):573-82. PubMed ID: 26666829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
    Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
    Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe.
    Moore LE; Hung R; Karami S; Boffetta P; Berndt S; Hsu CC; Zaridze D; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Mukeria A; Holcatova I; Yeager M; Chanock S; Garcia-Closas M; Rothman N; Chow WH; Brennan P
    Int J Cancer; 2008 Apr; 122(8):1710-5. PubMed ID: 18098291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.
    Zhang Y; Xia ZG; Zhu JH; Chen MB; Wang TM; Shen WX; He J
    Mol Genet Genomics; 2015 Dec; 290(6):2063-73. PubMed ID: 25977148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.